Seres Therapeutics, Inc.
NASDAQ:MCRB
1.05 (USD) • At close September 18, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -113.724 | -250.157 | -65.578 | -89.127 | -70.279 | -98.942 | -89.38 | -91.579 | -54.78 | -16.709 | -6.102 | -3.126 |
| Afschrijvingen & Amortisatie
| 15.114 | 6.629 | 5.947 | 6.578 | 7.603 | 7.862 | 7.259 | 4.205 | 0.728 | 0.19 | 0.088 | 0.025 |
| Uitgestelde Inkomstenbelasting
| -114.228 | 0 | 2.526 | 0 | 0.103 | 0 | 0 | 0 | 0.007 | 1.418 | 0.008 | -0.028 |
| Aandelen Gebaseerde Vergoedingen
| 34.101 | 25.482 | 20.222 | 8.824 | 8.344 | 16.641 | 17.362 | 16.857 | 9.694 | 2.068 | 0.209 | 0.028 |
| Verandering in Werkkapitaal
| -58.977 | -18.391 | 41.53 | -23.197 | -24.627 | 11.799 | -10.551 | 114.824 | 3.14 | 2.277 | 0.457 | 0.148 |
| Vorderingen
| -8.674 | 0 | 9.387 | -7.602 | -1.785 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| -29.647 | 0 | 27.138 | -2.871 | -3.862 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| -11.578 | 2.203 | 9.362 | -1.159 | -1.46 | -0.353 | -0.856 | 3.581 | 2.682 | 0.81 | 0.281 | 0.103 |
| Overig Werkkapitaal
| -9.078 | -20.594 | -4.357 | -11.565 | -17.52 | 12.152 | -9.695 | 111.243 | 0.458 | 1.467 | 0.176 | 0.045 |
| Overige Niet-Contante Posten
| 120.36 | 7.621 | 2.041 | 3.312 | 2.336 | -0.214 | -0.213 | -0.386 | 0.367 | 0.398 | 0.019 | 0.028 |
| Kasstroom uit Operationele Activiteiten
| -117.354 | -228.816 | 6.688 | -93.61 | -76.52 | -62.854 | -75.523 | 43.921 | -40.844 | -10.358 | -5.321 | -2.925 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -7.975 | -9.821 | -9.566 | -0.591 | -1.002 | -1.937 | -4.676 | -21.492 | -4.362 | -1.001 | -0.174 | -0.292 |
| Netto Overnames
| -18.557 | -92.249 | -73.654 | 19.9 | 29.516 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -4.426 | -48.221 | -95.971 | -218.284 | -46.42 | -21.832 | -96.534 | -290.594 | -267.761 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 22.983 | 140.47 | 169.625 | 59.984 | 16.904 | 136.087 | 158.312 | 246.494 | 136.39 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 18.557 | 92.249 | 73.654 | -19.9 | -29.516 | 114.255 | -0.113 | 0.139 | -1.4 | -0.102 | -0.01 | -0.027 |
| Kasstroom uit Investeringsactiviteiten
| 10.582 | 82.428 | 64.088 | -158.891 | -30.518 | 112.318 | 56.989 | -65.453 | -137.133 | -1.103 | -0.184 | -0.319 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -50.518 | -1.907 | -0.948 | -19.9 | -25 | 0 | 0 | 0 | -2.6 | -0.4 | -0.944 | 0 |
| Uitgifte van Gewone Aandelen
| 21.187 | 101.168 | 0.827 | 303.424 | 61.215 | 0.061 | 0.116 | 2.138 | 140.349 | 0.005 | 0 | 0.005 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | -0.197 | -0.033 | 0 | -0.024 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 101.036 | 30.341 | 1.299 | 303.424 | 50.016 | 0.404 | 0.116 | 2.138 | 140.325 | 124.387 | 0.944 | 9.43 |
| Kasstroom uit Financieringsactiviteiten
| 71.705 | 129.602 | 1.178 | 303.424 | 86.231 | 0.268 | 0.083 | 2.138 | 137.725 | 123.992 | 0.944 | 9.435 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.002 | -0.001 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -35.065 | -16.787 | 71.953 | 50.923 | -20.807 | 49.732 | -18.451 | -19.394 | -40.252 | 112.531 | -4.561 | 6.191 |
| Kaspositie aan het Einde van de Periode
| 127.965 | 171.215 | 188.002 | 116.049 | 65.126 | 85.933 | 36.088 | 54.539 | 73.933 | 114.185 | 1.654 | 6.215 |